Samalizumab is a humanized monoclonal antibody designed for oncology indications.Samalizumab was developed by Alexion Pharmaceuticals.
List of articles in "Drug" category - Page 62
Romosozumab
Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership […]
Ponezumab
Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer’s disease.Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase […]
Ozoralizumab
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.Ozoralizumab was developed by Pfizer Inc and now belongs to Ablynx NV.
Oxelumab
Oxelumab is a human monoclonal antibody designed for the treatment of asthma.Oxelumab was developed by Genentech and co-developed by Roche.
Onartuzumab
Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.Onartuzumab was developed by Genentech Inc.
Narnatumab
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.Narnatumab was developed by ImClone Systems.
Moxetumomab pasudotox
Moxetumomab pasudotox is an anti-CD22 mouse monoclonal antibody designed for the treatment of cancer.Moxetumomab pasudotox is currently being developed by the biologics division of AstraZeneca MedImmune.On 16 May 2013 the […]
Mogamulizumab
Mogamulizumab (USAN; trade name Poteligeo) is a humanized monoclonal antibody targeting CC chemokine receptor 4 (CCR4). It has been approved in Japan for the treatment of relapsed or refractory adult […]
Mavrilimumab
Mavrilimumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune Inc.